Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

essential pharma limited - apraclonidinhydrochlorid - øjendråber, opløsning - 10 mg/ml

Danmark - dansk - SEGES Landbrug & Fødevarer

adama northern europe b.v. - fluroxypyr - emulsionskoncentrat - 200 g/l fluroxypyr

Danmark - dansk - Adama

adama - florasulam 2,5 g/l + fluroxypyr 100 g/l (10.7 % w/w) - herbicider

Danmark - dansk - Adama

adama - florasulam 2,5 g/l + fluroxypyr 100 g/l (10.7 % w/w) - herbicider

Danmark - dansk - Adama

adama - 200 g/l fluroxypyr - herbicider

Danmark - dansk - SEGES Landbrug & Fødevarer

adama northern europe b.v. - florasulam, fluroxypyr - suspoemulsion - 2,5 g/l florasulam ; 100 g/l fluroxypyr

Danmark - dansk - SEGES Landbrug & Fødevarer

adama northern europe b.v. - fluroxypyr - emulsionskoncentrat - 180 g/l fluroxypyr

Den Europæiske Union - dansk - EMA (European Medicines Agency)

astellas pharma europe b.v. - enzalutamide - prostatiske neoplasmer - endokrine terapi - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

sanofi a/s - lenograstim - pulver og solvens til injektions- /infusionsvæske, opløsning - 13,4 mill. ie

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

pfizer aps - sertralinhydrochlorid - koncentrat til oral opløsning - 20 mg/ml